• GNPX Q1 2026 Earnings: Clinical-Stage Biotech Reports Net Loss Per Share of $0.64 Amid Ongoing Development - Margin Guidance dars.gov.et Tue, 30 Jun 2026 15:35:44 GMT
• GNPX Q1 2026 Earnings: Net Loss of $0.64 Per Share as Stock Climbs 5.03% - Forward Guidance Trends dars.gov.et Mon, 29 Jun 2026 07:47:37 GMT
• enterprise value to ebit forward of genprex, inc. – nasdaq:gnpx TradingView Thu, 25 Jun 2026 18:22:28 GMT
• Price to earnings forward of Genprex, Inc. – NASDAQ:GNPX TradingView Thu, 25 Jun 2026 16:38:09 GMT
• enterprise value to revenue forward of genprex, inc. – nasdaq:gnpx TradingView Thu, 25 Jun 2026 16:10:14 GMT
• gnpx stock news today | earnings, events & price alerts Intellectia AI Tue, 23 Jun 2026 09:47:09 GMT
• Genprex’s Reqorsa combo secures Canadian patent for lung cancer Pharmaceutical Technology Tue, 23 Jun 2026 07:00:00 GMT
• genprex (gnpx) secures new patent for reqorsa gene therapy GuruFocus Mon, 22 Jun 2026 14:24:20 GMT
• Form 8K Genprex Inc For: 22 June By Investing.com Investing.com Canada Mon, 22 Jun 2026 13:17:50 GMT
• genprex receives notice of allowance from the canadian intellectual property office for patent covering reqorsa gene therapy combi... marketscreener.com Mon, 22 Jun 2026 13:00:00 GMT
• genprex receives a notice of allowance from the canadian intellectual property office for a patent claiming the combination of req... Nasdaq Mon, 22 Jun 2026 13:00:00 GMT
• Genprex gets Canadian patent notice for cancer drug combo Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Genprex (NASDAQ: GNPX) secures Canadian patent for REQORSA lung cancer combinations Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Genprex receives Canadian patent allowance for cancer therapy combination Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Genprex Secures Canadian Patent for Reqorsa Lung Cancer Therapy TipRanks Mon, 22 Jun 2026 07:00:00 GMT
• genprex inc (gnpx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• genprex shareholders approve expanded equity plan, reverse split The Globe and Mail Fri, 19 Jun 2026 21:47:00 GMT
• genprex shareholders approve expanded equity plan, reverse split TipRanks Thu, 18 Jun 2026 21:35:04 GMT
• genprex inc (gnpx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:27:06 GMT
• Genprex Inc (GNPX) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Thu, 18 Jun 2026 09:18:09 GMT
• genprex inc (gnpx) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 08:58:37 GMT
• Genprex (NASDAQ: GNPX) OKs equity plan and reverse split range Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 12 health care stocks moving in thursday's after-market session Benzinga Thu, 18 Jun 2026 07:00:00 GMT
• genprex inc (gnpx) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 05:54:38 GMT
• genprex inc (gnpx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 05:35:56 GMT
• genprex inc (gnpx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 03:22:38 GMT
• genprex inc (gnpx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 03:16:29 GMT
• gnpx stock news today | earnings, events & price alerts Intellectia AI Wed, 17 Jun 2026 23:40:46 GMT
• genprex inc (gnpx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 22:47:16 GMT
• Genprex to Participate at BIO International Convention 2026 Morningstar Wed, 17 Jun 2026 07:00:00 GMT
• genprex faces nasdaq delisting notice, plans compliance steps TipRanks Tue, 16 Jun 2026 00:16:29 GMT
• gnpx q1 2026 earnings: continued losses as clinical-stage biotech focuses on pipeline progress - earnings miss streak newsline.com Mon, 15 Jun 2026 00:31:42 GMT
• Genprex Faces Nasdaq Delisting Notice, Plans Compliance Steps The Globe and Mail Sat, 13 Jun 2026 07:00:00 GMT
• Genprex, Inc. Files Form 8-K With Nasdaq Listing and Company Information – June 2026 Minichart Sat, 13 Jun 2026 07:00:00 GMT
• genprex faces potential delisting from nasdaq after bid price rule violation Investing.com UK Sat, 13 Jun 2026 04:18:32 GMT
• genprex faces nasdaq delisting notice, plans compliance steps TipRanks Fri, 12 Jun 2026 23:47:44 GMT
• genprex inc. (gnpx) edges higher amid low-volume consolidation near key support levels - mid cap momentum newsline.com Fri, 12 Jun 2026 14:42:44 GMT
• Genprex (NASDAQ: GNPX) confronts Nasdaq delisting risk after sub-$1 bid price Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Genprex faces potential delisting from Nasdaq after bid price rule violation Investing.com Fri, 12 Jun 2026 07:00:00 GMT
• genprex inc. (gnpx) edges higher on modest volume, faces key resistance at $0.68 - ma cross alert newsline.com Thu, 11 Jun 2026 23:37:34 GMT
• genprex q1 2026 earnings: net loss of $0.64 per share as clinical-stage operations continue - earnings surprise report newsline.com Sun, 07 Jun 2026 22:45:42 GMT
• genprex (gnpx) files shelf registration to sell up to $250m in securities Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• gnpx technical analysis | trend, signals & chart patterns | genprex inc (nasdaq:gnpx) ChartMill Thu, 04 Jun 2026 07:00:00 GMT
• GNPX Q1 2026 Earnings: Net Loss Widens as Clinical-Stage Biotech Advances Pipeline - Downward Estimate Revision dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• genprex (gnpx) drops 2.35% as stock nears key support at $0.69 - factor timing dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• Genprex (GNPX) Q1 2026 Earnings: Net Loss Per Share Reflects Preclinical Investment as Gene Therapy Pipeline Advances - Financial ... dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• genprex (gnpx) edges lower toward $0.75 support as biotech sentiment wavers - rating change The Legal Advocate Fri, 29 May 2026 14:31:28 GMT
• Genprex (GNPX) Slips 1.86% as Stock Tests Key Support at $0.74 - Sign of Strength dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• genprex inc. (gnpx) slides to $0.78 as stock continues to test key support - pcr divergence newsline.com Fri, 29 May 2026 07:00:00 GMT
• genprex (gnpx) q1 2026 earnings: continued r&d investment as gene therapy pipeline progresses - financial summary newsline.com Wed, 27 May 2026 21:30:35 GMT
• genprex reports positive reqorsa biomarker data at asco 2026 grafa.com Tue, 26 May 2026 16:41:00 GMT
• genprex, inc. announces positive clinical data on biomarkers in patients receiving reqorsa® gene therapy published at the 2026 asc... marketscreener.com Tue, 26 May 2026 13:51:24 GMT
• gnpx q1 2026 earnings: clinical-stage biotech reports net loss with no revenue; stock moves up $0.74 - operating income trends The Legal Advocate Tue, 26 May 2026 08:48:38 GMT
• Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting PR Newswire Tue, 26 May 2026 07:00:00 GMT
• genprex reports biomarker data from lung cancer gene therapy study by investing.com Investing.com Canada Tue, 26 May 2026 07:00:00 GMT
• genprex highlights biomarker data for reqorsa lung cancer therapy TipRanks Tue, 26 May 2026 07:00:00 GMT
• tumor protein pattern linked to longer control on lung cancer gene therapy Stock Titan Tue, 26 May 2026 07:00:00 GMT
• biomarker data link trop-2 to pfs in genprex (nasdaq: gnpx) trials Stock Titan Tue, 26 May 2026 07:00:00 GMT
• genprex inc. (gnpx) edges higher amid biotech sector cautious tone - quality etf newsline.com Fri, 22 May 2026 07:00:00 GMT
• genprex (gnpx) q1 2026 earnings stay the course — eps $-0.64 - eps miss report newsline.com Thu, 21 May 2026 07:00:00 GMT
• should i buy gnpx? gnpx 2026 analysis - intellectia ai™ Intellectia AI Fri, 15 May 2026 07:00:00 GMT
• genprex presents positive preclinical data on novel gene therapy for type 2 diabetes at asgct 2026 meeting geneonline.com Thu, 14 May 2026 12:33:11 GMT
• genprex data shows gene therapy reverses hyperglycemia in t2d mice at asgct TradingView Thu, 14 May 2026 12:13:01 GMT
• gene therapy reversed high blood sugar in type 2 diabetic mice in 4 weeks Stock Titan Thu, 14 May 2026 12:00:00 GMT
• Genprex, Inc. Files Form 8-K With SEC – Company Information and Filing Details for May 14, 2026 Minichart Thu, 14 May 2026 07:00:00 GMT
• genprex collaborators present positive preclinical data on diabetes gene therapy for type 2 diabetes at the 2026 american society ... PR Newswire Thu, 14 May 2026 07:00:00 GMT
• genprex collaborators present diabetes gene therapy data Investing.com Thu, 14 May 2026 07:00:00 GMT
• genprex (gnpx) showcases promising diabetes gene therapy results GuruFocus Thu, 14 May 2026 07:00:00 GMT
• [8-k] genprex, inc. reports material event | gnpx 8-k filing Stock Titan Thu, 14 May 2026 07:00:00 GMT
• genprex announces positive preclinical data for diabetes gene therapy TipRanks Thu, 14 May 2026 07:00:00 GMT
• genprex, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 13 May 2026 20:36:00 GMT
• genprex (nasdaq: gnpx) raises cash through share sales amid going concern risk Stock Titan Wed, 13 May 2026 07:00:00 GMT
• gnpx genprex quarterly results lack key metrics as clinical programs advance, investors await pipeline update. - guidance upgrade ... newsline.com Mon, 11 May 2026 07:00:00 GMT
• genprex (gnpx) warrant holders report 249,788 shares, 2.69% stake Stock Titan Mon, 11 May 2026 07:00:00 GMT
• genprex (gnpx) eps beats by 38% yet shares decline 2.84% as revenue questions linger. - revenue per share newsline.com Fri, 08 May 2026 07:00:00 GMT
• gnpx (genprex) q1 loss narrower than expected, beating estimates by 37.8% despite zero revenue and shares ticking higher. - revenu... newsline.com Fri, 08 May 2026 07:00:00 GMT
• what genprex (gnpx) is doing that changes everything (momentum building) 2026-05-06 - standard deviation newsline.com Wed, 06 May 2026 07:00:00 GMT
• top 3 health care stocks that are set to fly in q2 - genprex (nasdaq:gnpx), medtronic (nyse:mdt) Benzinga Wed, 06 May 2026 07:00:00 GMT
• gnpx forecast, price target & analyst ratings | genprex inc (nasdaq:gnpx) ChartMill Tue, 05 May 2026 07:00:00 GMT
• gnpx genprex reports narrower q1 2025 loss than estimates, shares drop 5.85 percent in today's trading. - profit guidance range newsline.com Sun, 03 May 2026 07:00:00 GMT
• Genprex, Inc. Files Form 8-K With SEC: Company Information, Nasdaq Listing, and Regulatory Details Minichart Fri, 01 May 2026 07:00:00 GMT
• gnpx forecast, price target & analyst ratings | genprex inc (nasdaq:gnpx) ChartMill Fri, 01 May 2026 07:00:00 GMT
• genprex secures patent for reqorsa gene therapy in cancer treatm GuruFocus Thu, 30 Apr 2026 18:11:15 GMT
• genprex, inc. files form 8-k with sec: company information, nasdaq listing, and regulatory details Minichart Thu, 30 Apr 2026 16:32:00 GMT
• israel grants genprex cancer-therapy patent tied to pd-1 drugs Stock Titan Thu, 30 Apr 2026 12:00:00 GMT
• Israel grants Genprex (NASDAQ: GNPX) patent for REQORSA lung cancer use Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• genprex receives patent grant from the israel patent office for the combination of reqorsa® gene therapy and pd-1 antibodies to tr... PR Newswire Thu, 30 Apr 2026 07:00:00 GMT
• genprex expands reqorsa cancer therapy patent protection in israel TipRanks Thu, 30 Apr 2026 07:00:00 GMT
• genprex (nasdaq: gnpx) seeks approval for equity plan and reverse stock split Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• genprex collaborators to present diabetes gene therapy data at may meeting by investing.com Investing.com Australia Wed, 29 Apr 2026 05:59:55 GMT
• genprex collaborators to present positive preclinical data on diabetes gene therapy for type 2 diabetes at the 2026 american socie... Yahoo Finance Tue, 28 Apr 2026 07:00:00 GMT
• genprex collaborators to present diabetes gene therapy data at may meeting Investing.com Canada Tue, 28 Apr 2026 07:00:00 GMT
• genprex highlights promising preclinical data for diabetes gene therapy TipRanks Tue, 28 Apr 2026 07:00:00 GMT
• genprex (gnpx) shows gpx-002 gene therapy reversed hyperglycemia in t2d mice Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• gnpx forecast, price target & analyst ratings | genprex inc (nasdaq:gnpx) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• genprex biomarker research selected for asco 2026 meeting by investing.com Investing.com Australia Thu, 23 Apr 2026 00:00:15 GMT
• genprex signs sponsored research agreement to study biomarkers that may predict patient response to reqorsa® gene therapy The Malaysian Reserve Wed, 22 Apr 2026 07:36:52 GMT
• genprex biomarker research selected for asco 2026 meeting Investing.com Wed, 22 Apr 2026 07:00:00 GMT
• lung cancer gene therapy study lands asco slot with biomarker data Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• positive clinical data on biomarkers in patients receiving reqorsa® gene therapy to be released at the 2026 asco annual meeting Yahoo Finance Wed, 22 Apr 2026 07:00:00 GMT
• genprex signs research deal to study lung cancer biomarkers by investing.com Investing.com Australia Wed, 22 Apr 2026 01:17:15 GMT
• Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy PR Newswire Tue, 21 Apr 2026 07:00:00 GMT
• Genprex (NASDAQ: GNPX) expands MD Anderson pact and reports Reqorsa lung cancer trial progress Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• Genprex (GNPX) Pops As Reqorsa Data Impresses At AACR 2026 timothysykes.com Tue, 21 Apr 2026 07:00:00 GMT
• genprex signs research deal to study lung cancer biomarkers Investing.com Tue, 21 Apr 2026 07:00:00 GMT
• genprex expands lung cancer gene therapy research collaboration TipRanks Tue, 21 Apr 2026 07:00:00 GMT
• can two biomarkers flag who benefits from genprex lung cancer therapy? Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• genprex enters md anderson research pact to study biomarkers for reqorsa in nsclc and sclc TradingView Tue, 21 Apr 2026 07:00:00 GMT
• genprex (gnpx) partners with md anderson for cancer research GuruFocus Tue, 21 Apr 2026 07:00:00 GMT
• genprex presents preclinical lung cancer therapy data at aacr by investing.com Investing.com India Tue, 21 Apr 2026 06:59:59 GMT
• genprex (gnpx) reveals promising lung cancer research at aacr 20 GuruFocus Mon, 20 Apr 2026 12:18:26 GMT
• Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at th... PR Newswire Mon, 20 Apr 2026 07:00:00 GMT
• Genprex presents preclinical lung cancer therapy data at AACR Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• lung cancer gene therapy from genprex shrank tumors, cleared some in mice Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• genprex announces presentations on reqorsa gene therapy at 2026 aacr TipRanks Mon, 20 Apr 2026 07:00:00 GMT
• gnpx forecast, price target & analyst ratings | genprex inc (nasdaq:gnpx) ChartMill Mon, 20 Apr 2026 07:00:00 GMT
• genprex | pre 14a: preliminary proxy statements relating to merger or acquisition Moomoo Fri, 17 Apr 2026 20:35:50 GMT
• genprex (nasdaq: gnpx) asks shareholders to ok 1:5–1:50 reverse split, equity plan Stock Titan Fri, 17 Apr 2026 20:34:54 GMT
Genprex, Inc(NASDAQ:GNPX) 
Genprex, Inc. operates as a clinical-stage gene therapy company that develops treatments for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new treatment options for patient populations with cancer and diabetes. Its lead pro...
Website: http://www.genprex.com
Founded: 2009
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology